Korean Heart Rhythm Society 2019 Practical Guidelines on Antithrombotic Therapy for AF Patients Undergoing Percutaneous Coronary Intervention or Structural Heart Disease Intervention / 대한내과학회지
Korean Journal of Medicine
; : 330-342, 2019.
Article
in Ko
| WPRIM
| ID: wpr-938588
Responsible library:
WPRO
ABSTRACT
The choice of an adequate antithrombotic regimen for atrial fibrillation patients undergoing emergent or elective percutaneous coronary intervention (PCI) should be based on the ischemic event and on the risk of bleeding. Recent randomized controlled trials have consistently demonstrated that dual antithrombotic therapeutic regimens, using non-vitamin K anticoagulants and clopidogrel, are superior to triple or dual therapy with warfarin and aspirin. This report incorporates findings of recent notable studies to provide concrete, clinically useful details and recommendations for bleeding risk assessment and optimal antithrombotic therapeutic strategies after PCI. In addition, we introduce guidelines for antithrombotic management after structural heart disease intervention.
Full text:
1
Index:
WPRIM
Type of study:
Clinical_trials
/
Guideline
/
Risk_factors_studies
Language:
Ko
Journal:
Korean Journal of Medicine
Year:
2019
Type:
Article